Medicus Sciences Acquisition Corp.

Medicus Sciences Acquisition Corp. (Nasdaq: MSAC) is a blank-check company focused on the healthcare and life sciences sector that completed its initial public offering in 2021. The SPAC was formed to identify and execute a merger or acquisition with a target operating in the biomedical or life sciences industry. MSAC filed an amended quarterly report, Form 10-Q/A, with the Securities and Exchange Commission on January 20, 2022, under accession number 0001104659-22-005991, representing an update to an earlier filing submitted during the company's active search for a business combination target. For complete filing history, sponsor background, and deal status on MSAC, sign up for full access at SpacDesk.